Stock listing

Neurizon Therapeutics Limited

Selected listing: ECQ0 · SWB · EUR · DE

Neurizon Therapeutics Limited (Stuttgart:ECQ0), Health Technology. Latest release Oct 5, 2026: FDA Type C Feedback, HEALEY trial potentially registrational.

ECQ0:SWBEURDEUpdated October 2, 2026
Neurizon Therapeutics Limited logo
Ticker
Stuttgart:ECQ0
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Stuttgart
Currency
EUR

About Neurizon Therapeutics Limited

The company is focused on developing innovative therapeutic solutions. Neurizon aims to address unmet medical needs through its research and development efforts.

Latest news from Neurizon Therapeutics Limited

All Neurizon Therapeutics Limited news →

Research Neurizon Therapeutics Limited

Alternate listings